Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with an early stage of non-small cell lung cancer (a common type of lung cancer)
- People for whom surgery to remove the cancer has been recommended
- People who are able to understand the trial information and agree to take part
- People who are covered by health insurance
Who may not be able to join:
- People who have had another type of cancer within the last 5 years
- People who have a known allergy to contrast medium (a special dye sometimes used in medical scans)
- People who are under a legal protection order (a legal arrangement where someone else manages a person's affairs)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Julien MAZIERES, MD, PhD, University Hospital, Toulouse
Phone: 0567771837
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Algorithm for disease free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.